The PACCARB establishes Working Groups (WG) composed of council members and federal representatives based on the task/s assigned by the Secretary of HHS, or priorities set by the Chairs of the PACCARB. Utilizing a consistent One Health approach to address tasks, each WG is co-chaired by voting members with human health and animal health expertise. External stakeholders participate on closed WG group sessions as presenters for fact-finding purposes. Once a WG has completed its task and produced a report with recommendations, that deliverable is presented to the full PACCARB for deliberation and vote at a public meeting. After the draft report has been voted on, the WG is on standby until another task has been assigned, or new WGs are established, as appropriate.
The PACCARB WGs and their most current deliverables are listed below in chronological order of establishment:
Immediate Action Subcommittee (status: active)
- Mission: Provide recommendations addressing topics of immediate concern related to antibiotic resistance
Report: A letter with recommendations drafted by the Immediate Action Subcommittee, One-page letter, was voted and approved at the April 2019 public meeting.
Reports: Two letters with recommendations drafted by the Immediate Action Subcommittee, Resolution 1 and Resolution 2, were voted and approved at the March 2018 public meeting.
Antibiotic Access and Use Working Group (status: on standby)
- Mission: Investigate differences in perception and usage of antibiotics across the One Health spectrum and provide recommendations identifying any knowledge gaps that future research can address.
Report: AA&U WG Final Report*. Voted and approved at the June 29, 2021 public meeting.
Inter-Professional Education Working Group (status: on standby)
- Mission: Investigate how inter-professional education and practice (IPE) can be used to improve antibiotic stewardship and infection prevention curricula. Provide recommendations on how to incorporate IPE to strengthen training, national and state board certification and accreditation, and continuing education of health science professionals.
Report: IP&E WG Final Report*. Voted and approved at the June 29, 2021 public meeting.
Working Group on Strategic Planning (status: active)
- Mission: Collect data and perform outreach to plan and inform the strategic direction of Council tasks.
Report: on-going
Working Group on the National Action Plan for Combating Antibiotic Resistant Bacteria (CARB) 2019 (status: on standby)
- Mission: Explore current policies, review new research findings and discoveries, and identify emerging priorities to inform and support the goals of the National Action Plan for CARB 2020-2025.
Report: NAP WG Final Report. Voted and approved at the July 10, 2019 public meeting.
Working Group on Infection Prevention and Stewardship (status: on standby)
- Mission: Critically explore and evaluate federal programs related to infection prevention and stewardship for animal and human health.
Report: IP&S WG Final Report. Voted and approved at the September 26, 2018 public meeting.
Working Group on Incentives for the Development of Products to Combat Antibiotic Resistance (status: on standby)
- Mission: Address the best way to incentivize the development of therapeutics/anti-infectives (including alternatives to antibiotics), rapid diagnostics, and vaccines for both humans and animals.
Report: Recommendations for Incentivizing the Development of Vaccines, Diagnostics, and Therapeutics to Combat Antibiotic-Resistance. Voted and approved at the September 2017 public meeting.
Working Groups on Goals 1-5 of the National Action Plan (status: inactive)
- Mission: Provide the Advisory Council with a summary of findings on federal and non-federal efforts as they relate to the 5 goals of the NAP.
Report: Initial Assessments of the National Action Plan on CARB. Voted and approved at the March 2016 public meeting.
*People using assistive technology may not be able to fully access information in these files. For assistance, contact the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria by emailing [email protected].
